GlassScriptPhysician profile
Anjali Bhasin
NPI 1104895887
$52,446.80
in general payments reported to CMS, 2019-2025
16 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $91.59 · 2021: $230 · 2022: $353 · 2023: $640 · 2024: $614 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $49,987.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $541.57 | 2021-2024 | Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $503.12 | 2021-2025 | Nucala, Arexvy |
| Lilly USA, LLC | $267.64 | 2023-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $178.75 | 2022-2025 | Wegovy |
| Amgen INC. | $155.41 | 2023 | Repatha, Evenity, Otezla |
| Galderma Laboratories, L.P. | $125.00 | 2025 | Nemluvio |
| Pharming Healthcare, INC. | $125.00 | 2024 | Ruconest |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2023 | |
| Csl Behring | $101.75 | 2024 | Hizentra |
| Genzyme Corporation | $98.33 | 2025 | |
| Mylan Specialty L.P. | $91.59 | 2020 | |
| Abbott Laboratories | $59.16 | 2023 | Proclaim |
| Pfizer INC. | $47.62 | 2023 | |
| Esperion Therapeutics, INC. | $22.30 | 2024 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Bhasin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.